These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11941026)

  • 21. Influence of aminoglutethimide and spironolactone on the efficacy of carbamazepine and diphenylhydantoin against amygdala-kindled seizures in rats.
    Borowicz KK; Czuczwar SJ
    Eur J Pharmacol; 2005 Jun; 516(3):212-8. PubMed ID: 15958264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticonvulsants during electroconvulsive therapy: review and recommendations.
    Sienaert P; Peuskens J
    J ECT; 2007 Jun; 23(2):120-3. PubMed ID: 17548985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticonvulsant effects of the selective melatonin receptor agonist ramelteon.
    Fenoglio-Simeone K; Mazarati A; Sefidvash-Hockley S; Shin D; Wilke J; Milligan H; Sankar R; Rho JM; Maganti R
    Epilepsy Behav; 2009 Sep; 16(1):52-7. PubMed ID: 19682955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice.
    Swiader M; Wielosz M; Czuczwar SJ
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):307-18. PubMed ID: 15163441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus.
    Chen F; Madsen TM; Wegener G; Nyengaard JR
    Eur Neuropsychopharmacol; 2009 May; 19(5):329-38. PubMed ID: 19176277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local cerebral glucose utilization after chronic electroconvulsive shock: implications for the mode of action of electroconvulsive therapy.
    Lock T; McCulloch J
    J Psychopharmacol; 1991 Jan; 5(2):111-9. PubMed ID: 22282362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of carnosine on amygdaloid-kindled seizures in Sprague-Dawley rats.
    Jin CL; Yang LX; Wu XH; Li Q; Ding MP; Fan YY; Zhang WP; Luo JH; Chen Z
    Neuroscience; 2005; 135(3):939-47. PubMed ID: 16125861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ
    Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures.
    Szyndler J; Maciejak P; Turzyńska D; Sobolewska A; Taracha E; Skórzewska A; Lehner M; Bidziński A; Hamed A; Wisłowska-Stanek A; Krzaścik P; Płaźnik A
    Epilepsy Behav; 2009 Oct; 16(2):216-24. PubMed ID: 19713157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine.
    Post RM
    Pharmacopsychiatry; 1990 Jan; 23(1):3-17. PubMed ID: 2179972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal delivery of a thyrotropin-releasing hormone analog attenuates seizures in the amygdala-kindled rat.
    Veronesi MC; Kubek DJ; Kubek MJ
    Epilepsia; 2007 Dec; 48(12):2280-6. PubMed ID: 17651414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological mechanisms of action of electroconvulsive therapy.
    Sánchez González R; Alcoverro O; Pagerols J; Rojo JE
    Actas Esp Psiquiatr; 2009; 37(6):343-51. PubMed ID: 20066586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant actions of deoxycorticosterone.
    Perez-Cruz C; Lonsdale D; Burnham WM
    Brain Res; 2007 May; 1145():81-9. PubMed ID: 17368435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of ACTH and adrenocorticosteroids on seizure susceptibility in 15-day-old male rats.
    Edwards HE; Vimal S; Burnham WM
    Exp Neurol; 2002 May; 175(1):182-90. PubMed ID: 12009770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Use of Thyroid Hormone and ECT.
    Stern RA; Steketee MC; Durr AL; Prange AJ; Golden RN
    Convuls Ther; 1993; 9(4):285-292. PubMed ID: 11941224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats.
    Shannon HE; Eberle EL; Peters SC
    Neuropharmacology; 2005 Jun; 48(7):1012-20. PubMed ID: 15857628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Mohamed M; Czuczwar SJ
    Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
    Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of electroconvulsive shock seizures on behaviour induced by dopaminergic agonists and on immobility in the Porsolt test.
    Zarrindast MR; Sahebgharani M; Burnham WM
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):509-14. PubMed ID: 15589391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.